Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-06 to 2023-03-07
Current total value of award: $26.5
Description: 4560374799!METOCLOPRAMIDE INJECT